Close Menu

NEW YORK — Henry Schein said on Thursday that it has signed an agreement to distribute SD Biosensor's point-of-care immunochromatography test for SARS-CoV-2 in the US.

According to Henry Schein, the Standard Q COVID-19 IgM/IgG Rapid Test is designed for the qualitative presumptive detection of specific IgM and IgG antibodies to SARS-CoV-2 in a fingerstick blood sample. Results are available within 15 minutes with no instrumentation required.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.